112 related articles for article (PubMed ID: 9380527)
1. [Genetic risk after high dose radioiodine therapy with regard to gonadal dose].
Ehrenheim C; Hauswirth C; Fitschen J; Martin E; Oetting G; Hundeshagen H
Nuklearmedizin; 1997 Aug; 36(5):157-66. PubMed ID: 9380527
[TBL] [Abstract][Full Text] [Related]
2. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma.
Fard-Esfahani A; Hadifar M; Fallahi B; Beiki D; Eftekhari M; Saghari M; Takavar A
Hell J Nucl Med; 2009; 12(1):37-40. PubMed ID: 19330181
[TBL] [Abstract][Full Text] [Related]
5. [Offsprings of preconceptionally irradiated parents. Final report of a longitudinal study 1976-1994 and recommendations for patients' advisory].
Herrmann T; Thiede G; Trott KR; Voigtmann L
Strahlenther Onkol; 2004 Jan; 180(1):21-30. PubMed ID: 14704841
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report.
Arndt D; Mehnert WH; Franke WG; Woller P; Laude G; Rockel A; Waller M
Strahlenther Onkol; 1994 Jul; 170(7):408-14. PubMed ID: 8052940
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
Chow SM; Yau S; Lee SH; Leung WM; Law SC
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
[TBL] [Abstract][Full Text] [Related]
8. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
9. Ovarian function after radioiodine therapy in patients with thyroid cancer.
Souza Rosário PW; Alvarenga Fagundes T; Villas-Boas Fagundes AS; Barroso AL; Lamego Rezende L; Lanza Padrão E; Guimarães VC; Horta AC; Franco M; Purisch S
Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):331-3. PubMed ID: 15977100
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma.
Balenović A; Vlasić M; Sonicki Z; Bodor D; Kusić Z
Coll Antropol; 2006 Dec; 30(4):743-8. PubMed ID: 17243543
[TBL] [Abstract][Full Text] [Related]
11. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
12. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.
Sarkar SD; Beierwaltes WH; Gill SP; Cowley BJ
J Nucl Med; 1976 Jun; 17(6):460-4. PubMed ID: 944243
[TBL] [Abstract][Full Text] [Related]
13. Malformations in the offspring of women with thyroid cancer treated with radioiodine for the ablation of thyroid remnants.
do Rosário PW; Barroso AL; Rezende LL; Padrão EL; Borges MA; Purisch S
Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):930-3. PubMed ID: 17160219
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
[TBL] [Abstract][Full Text] [Related]
16. Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study.
Zettinig G; Hanselmayer G; Fueger BJ; Hofmann A; Pirich C; Nepp J; Dudczak R
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1428-32. PubMed ID: 12397459
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 3,3'-Dimethylbenzidine Dihydrochloride (CAS No. 612-82-8) in F344/N Rats (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1991 Jun; 390():1-238. PubMed ID: 12637969
[TBL] [Abstract][Full Text] [Related]
19. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
